Serum gamma-seminoprotein determination in prostatic cancer

Serum gamma-seminoprotein (gamma-Sm) was evaluated as a new marker for prostatic cancer in comparison with prostatic acid phosphatase (PAP). The sensitivity of gamma-Sm and PAP for untreated prostatic cancer was 81% and 67%, respectively. gamma-Sm showed a higher positive rate over all stages than i...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 37(1991), 4 vom: 01. Apr., Seite 341-7
1. Verfasser: Shimazaki, J (VerfasserIn)
Weitere Verfasser: Akimoto, S, Akakura, K, Yoshiki, T, Yoshida, O, Okada, K, Matsuoka, K, Noda, S, Eto, K
Format: Aufsatz
Sprache:English
Veröffentlicht: 1991
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Comparative Study Journal Article Antigens, Neoplasm Biomarkers, Tumor Prostatic Secretory Proteins Proteins Seminal Plasma Proteins beta-microseminoprotein Acid Phosphatase EC 3.1.3.2